The Mycobacterial Cell Wall--Peptidoglycan and Arabinogalactan
- PMID:25818664
- PMCID: PMC4526729
- DOI: 10.1101/cshperspect.a021113
The Mycobacterial Cell Wall--Peptidoglycan and Arabinogalactan
Abstract
The mycobacterial bacillus is encompassed by a remarkably elaborate cell wall structure. The mycolyl-arabinogalactan-peptidoglycan (mAGP) complex is essential for the viability of Mycobacterium tuberculosis and maintains a robust basal structure supporting the upper "myco-membrane." M. tuberculosis peptidoglycan, although appearing to be unexceptional at first glance, contains a number of unique molecular subtleties that become particularly important as the TB-bacilli enters into nonreplicative growth during dormancy. Arabinogalactan, a highly branched polysaccharide, serves to connect peptidoglycan with the outer mycolic acid layer, and a variety of unique glycolsyltransferases are used for its assembly. In this review, we shall explore the microbial chemistry of this unique heteropolysacchride, examine the molecular genetics that underpins its fabrication, and discuss how the essential biosynthetic process might be exploited for the development of future anti-TB chemotherapies.
Copyright © 2015 Cold Spring Harbor Laboratory Press; all rights reserved.
Similar articles
- Assembly of the Mycobacterial Cell Wall.Jankute M, Cox JA, Harrison J, Besra GS.Jankute M, et al.Annu Rev Microbiol. 2015;69:405-23. doi: 10.1146/annurev-micro-091014-104121.Annu Rev Microbiol. 2015.PMID:26488279Review.
- Lcp1 Is a Phosphotransferase Responsible for Ligating Arabinogalactan to Peptidoglycan in Mycobacterium tuberculosis.Harrison J, Lloyd G, Joe M, Lowary TL, Reynolds E, Walters-Morgan H, Bhatt A, Lovering A, Besra GS, Alderwick LJ.Harrison J, et al.mBio. 2016 Aug 2;7(4):e00972-16. doi: 10.1128/mBio.00972-16.mBio. 2016.PMID:27486192Free PMC article.
- Mycobacterial cell wall biosynthesis: a multifaceted antibiotic target.Abrahams KA, Besra GS.Abrahams KA, et al.Parasitology. 2018 Feb;145(2):116-133. doi: 10.1017/S0031182016002377. Epub 2016 Dec 15.Parasitology. 2018.PMID:27976597Free PMC article.Review.
- Unraveling the Structure of the Mycobacterial Envelope.Daffé M, Marrakchi H.Daffé M, et al.Microbiol Spectr. 2019 Jul;7(4):10.1128/microbiolspec.gpp3-0027-2018. doi: 10.1128/microbiolspec.GPP3-0027-2018.Microbiol Spectr. 2019.PMID:31267927Free PMC article.Review.
- Exposure of mycobacteria to cell wall-inhibitory drugs decreases production of arabinoglycerolipid related to Mycolyl-arabinogalactan-peptidoglycan metabolism.Rombouts Y, Brust B, Ojha AK, Maes E, Coddeville B, Elass-Rochard E, Kremer L, Guerardel Y.Rombouts Y, et al.J Biol Chem. 2012 Mar 30;287(14):11060-9. doi: 10.1074/jbc.M111.327387. Epub 2012 Feb 7.J Biol Chem. 2012.PMID:22315220Free PMC article.
Cited by
- Proteomics from compartment-specific APEX2 labeling in Mycobacterium tuberculosis reveals Type VII secretion substrates in the cell wall.Jaisinghani N, Previti ML, Andrade J, Askenazi M, Ueberheide B, Seeliger JC.Jaisinghani N, et al.Cell Chem Biol. 2024 Mar 21;31(3):523-533.e4. doi: 10.1016/j.chembiol.2023.10.013. Epub 2023 Nov 14.Cell Chem Biol. 2024.PMID:37967559Free PMC article.
- Graphene oxide prevents mycobacteria entry into macrophages through extracellular entrapment.De Maio F, Palmieri V, Salustri A, Perini G, Sanguinetti M, De Spirito M, Delogu G, Papi M.De Maio F, et al.Nanoscale Adv. 2019 Jan 16;1(4):1421-1431. doi: 10.1039/c8na00413g. eCollection 2019 Apr 9.Nanoscale Adv. 2019.PMID:36132595Free PMC article.
- BALF metagenomic next-generation sequencing analysis in hematological malignancy patients with suspected pulmonary infection: clinical significance of negative results.Deng Z, Tang Y, Tu Y, Liu M, Cheng Q, Zhang J, Liu F, Li X.Deng Z, et al.Front Med (Lausanne). 2023 Jun 28;10:1195629. doi: 10.3389/fmed.2023.1195629. eCollection 2023.Front Med (Lausanne). 2023.PMID:37457591Free PMC article.
- Global phenotypic profiling identifies a conserved actinobacterial cofactor for a bifunctional PBP-type cell wall synthase.Sher JW, Lim HC, Bernhardt TG.Sher JW, et al.Elife. 2020 Mar 13;9:e54761. doi: 10.7554/eLife.54761.Elife. 2020.PMID:32167475Free PMC article.
- New therapeutic strategies forMycobacterium abscessus pulmonary diseases - untapping the mycolic acid pathway.Alcaraz M, Edwards TE, Kremer L.Alcaraz M, et al.Expert Rev Anti Infect Ther. 2023 Jul-Dec;21(8):813-829. doi: 10.1080/14787210.2023.2224563. Epub 2023 Jun 23.Expert Rev Anti Infect Ther. 2023.PMID:37314394Free PMC article.Review.
References
- Adam A, Petit JF, Wietzerbin-Falszpan J, Sinay P, Thomas DW, Lederer E. 1969. L’acide N-glycolylmuramique, constituant des parois de Mycobacterium smegmatis: Identification par spectrometrie de masse. FEBS Lett 4: 87–92. - PubMed
- Alderwick LJ, Radmacher E, Seidel M, Gande R, Hitchen PG, Morris HR, Dell A, Sahm H, Eggeling L, Besra GS. 2005. Deletion of Cg-emb in Corynebacterianeae leads to a novel truncated cell wall arabinogalactan, whereas inactivation of Cg-ubiA results in an arabinan-deficient mutant with a cell wall galactan core. J Biol Chem 280: 32362–32371. - PubMed
- Alderwick LJ, Dover LG, Seidel M, Gande R, Sahm H, Eggeling L, Besra GS. 2006a. Arabinan-deficient mutants of Corynebacterium glutamicum and the consequent flux in decaprenylmonophosphoryl-d-arabinose metabolism. Glycobiology 16: 1073–1081. - PubMed
- Alderwick LJ, Seidel M, Sahm H, Besra GS, Eggeling L. 2006b. Identification of a novel arabinofuranosyltransferase (AftA) involved in cell wall arabinan biosynthesis in Mycobacterium tuberculosis. J Biol Chem 281: 15653–15661. - PubMed
- Alderwick LJ, Dover LG, Veerapen N, Gurcha SS, Kremer L, Roper DL, Pathak AK, Reynolds RC, Besra GS. 2008. Expression, purification and characterisation of soluble GlfT and the identification of a novel galactofuranosyltransferase Rv3782 involved in priming GlfT-mediated galactan polymerisation in Mycobacterium tuberculosis. Protein Expr Purif 58: 332–341. - PubMed
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources